Medicare Advantage plans are changing their quality ratings, with the Centers for Medicare & Medicaid Services (CMS) ...

Teva Pharmaceutical Industries will pay $450 to settle the Department of Justice's investigation into allegations of price fixing and misuse of funds for kickbacks. Other pharmaceutical news reports ...

The cuts are part of a large-scale, $2 billion savings plan unveiled by executives in August. The Woonsocket, Rhode ...

The U.S. government on Thursday announced quality ratings for 2025 Medicare health and prescription drug plans, the first ...

Medicare Advantage plans are government Medicare benefits provided through for-profit insurers, so plan terms can — and do — change ...

CVS Health subsidiary Aetna holds 88% percent of members in plans rated four or more, down from 90.8%. CMS will designate ...

CVS Health, one of the biggest players in the battle to acquire physicians, is facing a possible split amid major financial struggles. In 2023, CVS Health spent $10.6 billion to acquire primary care ...

On the heels of its recent announcement that CVS Health will eliminate about 2,900 jobs nationwide, the health care giant is ...

Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.

CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare ...

CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The ...

A federal antitrust watchdog is conducting an investigation into, and has filed suit against, huge pharmacy middlemen. Two ...